ISA Pharmaceuticals
Leiden
About ISA Pharmaceuticals
ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent virus infections. The Company has built a proprietary immunotherapy platform based on its Synthetic Long Peptide (SLP®) concept and its AMPLIVANT® technology. SLP® immunotherapies are designed to fully harness and direct the body’s own defense mechanisms towards fighting the disease, either alone or in combination with existing therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $63.2M
- Last round: Series Unknown (Jul 2021)
- Website: isa-pharma.com
- Phone: (713) 322-310
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/isa-pharmaceuticals-156219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.